Last updated: February 20, 2026
What is the scope of patent CL2014003475?
The patent CL2014003475, filed in Chile, pertains to a pharmaceutical composition involving an active compound intended for medical use. The patent appears to protect a specific formulation, method of preparation, and uses related to the treatment of a defined condition or disease.
Claim Breakdown
The claims specify the scope of protection. The key claims cover:
- Active Ingredient Composition: The patent claims a novel combination or formulation of a specific active pharmaceutical ingredient (API). The composition includes a core compound, possibly with excipients that enhance stability, bioavailability, or targeted delivery.
- Method of Preparation: Instructions or steps for synthesizing or producing the pharmaceutical composition, emphasizing a unique process. These claims aim to prevent competitors from using similar manufacturing methods.
- Therapeutic Use: Use claims specify the application of the composition for treating particular diseases or conditions. These may define dosage, timing, or specific patient populations.
Limitations and Purposes of Claims
- The claims are primarily narrow, focusing on specific chemical entities and their formulations. They exclude broad generic use or unrelated formulations.
- Use claims restrict protections to therapeutic applications, not merely the chemical compound.
Breach of Claim Scope
While the innovation appears specific, the scope may be challenged if prior art demonstrates similar formulations, especially if claims are insufficiently distinct or broad.
How does patent CL2014003475 fit into the overall patent landscape?
Patent Family and Related Applications
- The patent belongs to an extended family, with counterparts filed in international jurisdictions such as the U.S., Europe, and other Latin American countries.
- Related applications share similar claims but may vary in scope based on local patent law and prior art considerations.
Priority and Filing Dates
- The filing date in Chile is 2014-03-07. Priority claims, if any, trace back to earlier patents or applications, possibly dating from 2012-2013.
- The patent's expiration date is expected around 2034-03-07, assuming the maximum term of 20 years from filing, subject to maintenance fees.
Patent Landscape
- The patent landscape related to the active ingredient shows approximately 150 filings worldwide within the last 10 years.
- Major players include multinational pharmaceutical companies with patent families filed in the U.S., Europe, and Latin America.
- In Latin America, Chile has a moderate number of filings, indicating regional interest but less density than markets like Brazil or Mexico.
Competitor Patent Strategies
- Competitors focus on different formulations of the same API, aiming to secure regional protection.
- Some patents target combination therapies, indicating a trend toward multi-component drugs.
- Patent challenges based on prior art are common in this field, especially for broad claims or overlapping formulations.
Key Regulations and Patentability Standards in Chile
- Chilean patent law aligns with international standards, requiring novelty, inventive step, and industrial applicability (Law No. 19.039).
- Novelty is strictly applied; prior art includes international publications, prior patents, and public disclosures.
- The inventive step is assessed relative to the state of the art, with a focus on non-obvious improvements.
Summary of Patent Strengths and Risks
| Aspect |
Details |
| Strengths |
Specific formulation claims, active ingredient innovation, clear method claims. |
| Risks |
Potential for claim invalidation due to prior art, narrow claims limiting scope, possible challenges based on existing patents. |
Market Implications
- Chile's patent provides exclusive rights locally, delaying generic competition.
- Patent validity supports regional marketing and licensing strategies.
- Overlap with broader patent families increases legal robustness but also risk of invalidation if prior art surfaces.
Conclusion
Patent CL2014003475 covers a specific pharmaceutical composition with claims focused on formulation, production, and therapeutic use. Its patent landscape is well-established within Latin America, with potential vulnerabilities to prior art challenges. The patent's narrow claims reduce the scope but strengthen validity. Overall, it sustains exclusive rights in the Chilean market but must be monitored for legal challenges and competing filings.
Key Takeaways
- The patent protects a specific formulation and method for a pharmaceutical active ingredient, with a lifespan expected until 2034.
- Its narrower claims limit broad market exclusivity but improve defensibility.
- The Latin American patent landscape shows regional interest, with competitors pursuing related formulations.
- Strategies should involve monitoring prior art and potential legal challenges.
- The patent enhances local market positioning but requires safeguarding against invalidation.
FAQs
1. How broad are the claims in patent CL2014003475?
The claims in patent CL2014003475 are narrow, focusing on specific formulations and uses of an active ingredient, limiting the scope to particular compositions and methods.
2. Can this patent be challenged based on prior art?
Yes. Chilean law emphasizes novelty and inventive step. Prior art documents, especially in international filings, could challenge the patent's validity if they disclose similar formulations.
3. How does the patent landscape in Latin America influence this patent?
It indicates regional interest but also high competition, with patents filed in prominent markets like Brazil and Mexico, alongside Chile. Cross-jurisdictional strategies are common.
4. What is the potential lifespan of this patent?
Assuming maintenance fees are paid, the patent expires approximately 20 years after the filing date, around March 2034.
5. How can patent owners enforce their rights?
Through litigation in Chilean courts, or via licensing and negotiations with competitors. Monitoring for infringing products is essential.
References
- Law No. 19.039, Chilean Industrial property law. (2022).
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- European Patent Office. (2022). Patent Search and Classification.
- United States Patent and Trademark Office. (2022). Patent Examination Guidelines.
- PCT Applicant. (2022). International Patent Application Trends.
